Retinoic acid-induced granulocytic differentiation of HL-60 myeloid leukemia cells is mediated directly through the retinoic acid receptor (RAR-alpha) - PubMed (original) (raw)
Retinoic acid-induced granulocytic differentiation of HL-60 myeloid leukemia cells is mediated directly through the retinoic acid receptor (RAR-alpha)
S J Collins et al. Mol Cell Biol. 1990 May.
Abstract
Retinoic acid (RA) induces terminal granulocytic differentiation of the HL-60 promyelocytic leukemia cell line as well as certain other human myeloid leukemias. Specific RA receptors that are members of the steroid-thyroid hormone superfamily of nuclear transcription factors have recently been identified. We developed an HL-60 subclone that was relatively resistant to RA-induced differentiation. Specific nuclear RA receptors in this RA-resistant subclone had a decreased affinity for RA and exhibited a lower molecular weight compared with nuclear RA receptors from the RA-sensitive parental HL-60 cells. Retroviral vector-mediated transduction of a single copy of the RA receptor (RAR-alpha) into this RA-resistant HL-60 subclone restored the sensitivity of these cells to RA. These observations indicate that RAR-alpha plays a critical and central role in mediating RA-induced terminal differentiation of HL-60 leukemia cells.
Comment in
- Molecular Characteristics and Clinical Significance of 12 Fusion Genes in Acute Promyelocytic Leukemia: A Systematic Review.
Yan W, Zhang G. Yan W, et al. Acta Haematol. 2016;136(1):1-15. doi: 10.1159/000444514. Epub 2016 Apr 19. Acta Haematol. 2016. PMID: 27089249
Similar articles
- Retinoic acid receptors in myeloid leukemia: characterization of receptors in retinoic acid-resistant K-562 cells.
Robertson KA, Mueller L, Collins SJ. Robertson KA, et al. Blood. 1991 Jan 15;77(2):340-7. Blood. 1991. PMID: 1670759 - Retinoic acid-induced expression of CD38 antigen in myeloid cells is mediated through retinoic acid receptor-alpha.
Drach J, McQueen T, Engel H, Andreeff M, Robertson KA, Collins SJ, Malavasi F, Mehta K. Drach J, et al. Cancer Res. 1994 Apr 1;54(7):1746-52. Cancer Res. 1994. PMID: 7511050 - Multiple members of the retinoic acid receptor family are capable of mediating the granulocytic differentiation of HL-60 cells.
Robertson KA, Emami B, Mueller L, Collins SJ. Robertson KA, et al. Mol Cell Biol. 1992 Sep;12(9):3743-9. doi: 10.1128/mcb.12.9.3743-3749.1992. Mol Cell Biol. 1992. PMID: 1324405 Free PMC article. - Annual guest lecture, Leukaemia Research Fund (UK): differentiation therapy and leukemia.
Degos L. Degos L. Leukemia. 1993 May;7(5):766-72. Leukemia. 1993. PMID: 8387125 Review. No abstract available.
Cited by
- History of Developing Acute Promyelocytic Leukemia Treatment and Role of Promyelocytic Leukemia Bodies.
Bercier P, de Thé H. Bercier P, et al. Cancers (Basel). 2024 Mar 29;16(7):1351. doi: 10.3390/cancers16071351. Cancers (Basel). 2024. PMID: 38611029 Free PMC article. Review. - Retinoic acid receptor regulation of decision-making for cell differentiation.
Brown G. Brown G. Front Cell Dev Biol. 2023 Apr 4;11:1182204. doi: 10.3389/fcell.2023.1182204. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 37082619 Free PMC article. Review. - Imidazo[1,2-b]pyrazole-7-Carboxamide Derivative Induces Differentiation-Coupled Apoptosis of Immature Myeloid Cells Such as Acute Myeloid Leukemia and Myeloid-Derived Suppressor Cells.
Kotogány E, Balog JÁ, Nagy LI, Alföldi R, Bertagnolo V, Brugnoli F, Demjén A, Kovács AK, Batár P, Mezei G, Szabó R, Kanizsai I, Varga C, Puskás LG, Szebeni GJ. Kotogány E, et al. Int J Mol Sci. 2020 Jul 20;21(14):5135. doi: 10.3390/ijms21145135. Int J Mol Sci. 2020. PMID: 32698503 Free PMC article. - Acute promyelocytic leukemia (APL): a review of the literature.
Jimenez JJ, Chale RS, Abad AC, Schally AV. Jimenez JJ, et al. Oncotarget. 2020 Mar 17;11(11):992-1003. doi: 10.18632/oncotarget.27513. eCollection 2020 Mar 17. Oncotarget. 2020. PMID: 32215187 Free PMC article. Review. - Strategies to generate functionally normal neutrophils to reduce infection and infection-related mortality in cancer chemotherapy.
Abdel-Azim H, Sun W, Wu L. Abdel-Azim H, et al. Pharmacol Ther. 2019 Dec;204:107403. doi: 10.1016/j.pharmthera.2019.107403. Epub 2019 Aug 27. Pharmacol Ther. 2019. PMID: 31470030 Free PMC article. Review.
References
- Jpn J Cancer Res. 1988 Apr;79(4):473-83 - PubMed
- Nature. 1988 Jun 16;333(6174):669-72 - PubMed
- Proc Natl Acad Sci U S A. 1988 Aug;85(15):5587-91 - PubMed
- J Biol Chem. 1988 Sep 25;263(27):13863-7 - PubMed
- Cell. 1988 Oct 7;55(1):145-56 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials